Social Media Ideas for Fda Approval

<![CDATA[Pharmaceutical Executive Daily: FDA Approves Datroway]]>

<![CDATA[Pharmaceutical Executive Daily: FDA Approves Utebzi and Capvaxive]]>

<![CDATA[Pharmaceutical Executive Daily: FDA Approves Xocova]]>

<![CDATA[Pharmaceutical Executive Daily: FDA Approves Ennumo]]>

HepQuant nabs FDA premarket approval for liver diagnostic test

The FDA has granted premarket approval to HepQuant’s liver diagnostic test for the treatment of adults with Child-Pugh Class A compensated cirrhosis, according to a company press r...

<![CDATA[Pharmaceutical Executive Daily: FDA Approves Hepcludex]]>

<![CDATA[FDA Approves Leqembi Iqlik Subcutaneous Injection for Early Alzheimer’s Disease]]>

<![CDATA[FDA Approves Ennumo to Decrease Incidence of Infection by Febrile Neutropenia ]]>

<![CDATA[FDA Approves Xocova as First Oral Post-Exposure Covid-19 Prevention Therapy]]>

<![CDATA[Pharmaceutical Executive Daily: FDA Approves Subcutaneous Formulation of Leqembi Iqlik]]>

<![CDATA[FDA Sends CRL to Cingulate for CTx-1301]]>

<![CDATA[FDA Approves Hepcludex as First and Only Approved Treatment for Chronic Hepatitis Delta Virus]]>

<![CDATA[FDA Approves Datroway for Patients with Metastatic Triple-Negative Breast Cancer Who Are Not PD-1/PD-L1 Inhi...

<![CDATA[Ibrance Wins FDA Approval for HR-Positive, HER2-Positive Metastatic Breast Cancer Maintenance Therapy]]>

<![CDATA[FDA Approves Subcutaneous Sarclisa Escena for Multiple Myeloma ]]>

<![CDATA[FDA Accepts NDA for Giredestrant in ER-Positive Early-Stage Breast Cancer]]>

United Therapeutics nabs FDA approval for donor-lung assessment device

United Therapeutics has been given a premarket approval from the FDA for its LungFX device.

FDA approves KetoMed for fever in cattle with BRD

Generic ketoprofen injectable solution receives approval for control of BRD-associated pyrexia in certain beef and dairy cattle.

<![CDATA[Pharmaceutical Executive Daily: FDA Approves Baxdrostat]]>

<![CDATA[FDA Approves Revtorpyk for Treatment of Advanced HR-Positive, HER2-Negative Breast Cancer ]]>

FDA Issues Draft Guidance Clarifying Use of Form FDA 3542

<![CDATA[FDA Expands Enhertu in Early HER2-Positive Breast Cancer]]>

<![CDATA[Pharmaceutical Executive Daily: FDA Approves Subcutaneous Sarclisa Escena]]>

<![CDATA[Pharmaceutical Executive Daily: FDA has Approved Skinvive by Juvéderm]]>